Clear 7°. Wind Chill: -10°. Wind: W 14 mph.
Loading advertisement…
Trending: New diet guidelines say to double up on protein, but nutrition experts are wary
HomeNewsNationalHealth ( Page 83)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Illinois quick hits: Report: $17,300 state debt per person; Metro East crime suppression operations

Report: $17,300 state debt per person A new report from Reason Foundation shows that Illinois’ state government has $222 billion in debt, third-most among all 50 states. ...
by

WATCH: Pritzker creates accountability commission amid increased immigration enforcement

(The Center Square) – In today's edition of Illinois in Focus Daily, The Center Square Editor Greg Bishop discusses the executive order Illinois Gov. J.B. Pritzker signed Thursday to create the Illinois Accountability Commission focused on taking witness testimony on alleged abused by immigration ...
by

Critics warn Illinois’ ‘megaproject’ tax breaks shift costs to taxpayers

(The Center Square) – A Springfield proposal grants major tax breaks to “megaprojects,” which critics warn could leave homeowners and small businesses paying the price. House Bill 4058, which ...
by

Eli Lilly to buy gene therapy developer Adverum in about $262 million deal

(Reuters) -Eli Lilly said on Friday it would acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to $261.7 million, aiming to strengthen its pipeline with an experimental eye disease treatment. The deal will give Lilly access to Adverum’s gene therapy candidate, ...
by

Novo Nordisk’s new chairman has ‘carte blanche’ after board clear-out

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, rattling investors despite calls for stronger leadership at the drugmaker behind weight-loss treatment Wegovy. Once Europe’s most valuable firm thanks ...
by

Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion

(Reuters) -Biogen said on Friday it has gained global rights to privately held Vanqua Bio’s experimental drug for up to $1.06 billion to expand its pipeline of immunology drugs. The oral drug targets a protein involved in various inflammatory disorders and is currently in preclinical ...
Loading advertisement…
by

UK seizes record haul of illegal weight-loss drugs in factory raid

LONDON (Reuters) -Britain’s medicines regulator on Friday said it had made the largest single seizure of trafficked weight loss medicines recorded globally, dismantling a factory making thousands of unlicensed weight-loss jabs. The Medicines and Healthcare products Regulatory Agency (MHRA) said it had seized 2,000 pens ...
by

Rapid early spread of bird flu in Europe raises fears of fresh crisis

By Sybille de La Hamaide PARIS (Reuters) -Bird flu is spreading rapidly in Europe, with the highest number of countries in at least a decade reporting early outbreaks, raising concerns about a repeat of past crises that led to the culling of tens of million ...
by

Eli Lilly reports promising data for alopecia and eczema drugs, eyes label expansion

(Reuters) -Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for alopecia and eczema. The company was testing baricitinib, sold under the brand name Olumiant, in 257 adolescent patients with severe alopecia areata or patchy hair ...
by

HCA Healthcare lifts annual forecasts on robust medical care demand

(Reuters) -HCA Healthcare raised its yearly profit and revenue forecasts on Friday as it expects sustained demand for medical procedures to cushion a hit from the Trump administration’s tariffs, sending its shares rising 5% in premarket trading. Hospital operators are expected to benefit from higher ...
by

Health Rounds: Combo drugs improve on chemo alone for certain breast cancer patients

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid (Reuters) -A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported ...
by

India’s Dr Reddy’s misses profit view on stiff US competition for generic cancer drug

(Reuters) -Indian generic drugmaker Dr Reddy’s Laboratories missed second-quarter profit estimates on Friday, hurt by higher costs and stiff competition for the generic version of the blockbuster cancer drug Revlimid in its key North America market. The company’s consolidated net profit came in at 13.47 ...
First Previous798081828384858687Next Last